//podcastplus.net/feed/podcast~fbde720144145a95193f353512a72d081a3ff5c0a4bf78e8db13693eee3e61b9 Pharmacy Revenue Cycle News aims to provide you with helpful tips, resources, and emerging updates that can improve your pharmacy revenue. We have one very simple goal. We take complex and ever changing rules and regulations to bring you awareness and practical tools that can help you understand and enhance your pharmacy revenue cycle. Our website is full of resources, tools, explanations and links that can help you navigate the pharmacy revenue cycle. Each newsletter provides you with practical tips for you to put into your practice. Fri, 10 Apr 2026 12:45:32 +0000 https://traffic.libsyn.com/secure/87d4129a-590b-43bb-a0af-5ff85eec4eed/230706PRC.mp3?dest-id=3288863 July 2023 is here and time to validate another round of quarterly updates from CMS. The JZ modifier, in addition to the JW modifier, is now required to effectively bill for drug waste (JW) and to attest when no drug was discarded (JZ) for all separately payable that are single-dose or single-use containers. Additionally, we have updated the Visante Quarterly Update Tool and the C9399 Tool to help organizations validate that their system is up to date with the recent changes.    Thu, 06 Jul 2023 18:24:14 +0000 https://traffic.libsyn.com/secure/87d4129a-590b-43bb-a0af-5ff85eec4eed/230706PRC.mp3?dest-id=3288863 https://traffic.libsyn.com/secure/87d4129a-590b-43bb-a0af-5ff85eec4eed/230706PRC.mp3?dest-id=3288863 July 2023 is here and time to validate another round of quarterly updates from CMS. The JZ modifier, in addition to the JW modifier, is now required to effectively bill for drug waste (JW) and to attest when no drug was discarded (JZ) for all separately payable that are single-dose or single-use containers. Additionally, we have updated the Visante Quarterly Update Tool and the C9399 Tool to help organizations validate that their system is up to date with the recent changes.    Thu, 06 Jul 2023 18:24:14 +0000 https://traffic.libsyn.com/secure/87d4129a-590b-43bb-a0af-5ff85eec4eed/230706PRC.mp3?dest-id=3288863 https://traffic.libsyn.com/secure/87d4129a-590b-43bb-a0af-5ff85eec4eed/230706PRC.mp3?dest-id=3288863 July 2023 is here and time to validate another round of quarterly updates from CMS. The JZ modifier, in addition to the JW modifier, is now required to effectively bill for drug waste (JW) and to attest when no drug was discarded (JZ) for all separately payable that are single-dose or single-use containers. Additionally, we have updated the Visante Quarterly Update Tool and the C9399 Tool to help organizations validate that their system is up to date with the recent changes.    Thu, 06 Jul 2023 18:24:14 +0000 https://traffic.libsyn.com/secure/87d4129a-590b-43bb-a0af-5ff85eec4eed/230706PRC.mp3?dest-id=3288863 https://traffic.libsyn.com/secure/87d4129a-590b-43bb-a0af-5ff85eec4eed/230706PRC.mp3?dest-id=3288863 July 2023 is here and time to validate another round of quarterly updates from CMS. The JZ modifier, in addition to the JW modifier, is now required to effectively bill for drug waste (JW) and to attest when no drug was discarded (JZ) for all separately payable that are single-dose or single-use containers. Additionally, we have updated the Visante Quarterly Update Tool and the C9399 Tool to help organizations validate that their system is up to date with the recent changes.    Thu, 06 Jul 2023 18:24:14 +0000 https://traffic.libsyn.com/secure/87d4129a-590b-43bb-a0af-5ff85eec4eed/230706PRC.mp3?dest-id=3288863 https://traffic.libsyn.com/secure/87d4129a-590b-43bb-a0af-5ff85eec4eed/032123PRC.mp3?dest-id=3288863 As a part of the Inflation Reduction Act of 2022, CMS is requiring manufacture rebates for certain Medicare Part B drugs in which the cost has exceeded inflation. Beneficiaries out of pocket costs will be reduced to 20% of the inflation-adjusted payment described in the Act. Tue, 21 Mar 2023 19:54:44 +0000 https://traffic.libsyn.com/secure/87d4129a-590b-43bb-a0af-5ff85eec4eed/032123PRC.mp3?dest-id=3288863 https://traffic.libsyn.com/secure/87d4129a-590b-43bb-a0af-5ff85eec4eed/032123PRC.mp3?dest-id=3288863 As a part of the Inflation Reduction Act of 2022, CMS is requiring manufacture rebates for certain Medicare Part B drugs in which the cost has exceeded inflation. Beneficiaries out of pocket costs will be reduced to 20% of the inflation-adjusted payment described in the Act. Tue, 21 Mar 2023 19:54:44 +0000 https://traffic.libsyn.com/secure/87d4129a-590b-43bb-a0af-5ff85eec4eed/032123PRC.mp3?dest-id=3288863 https://traffic.libsyn.com/secure/87d4129a-590b-43bb-a0af-5ff85eec4eed/20230222_Self_Administered_Drug_-_Refresh.mp3?dest-id=3288863 Self-administered drugs (SAD) have been a long-standing controversy when administered in a hospital outpatient setting from the perspectives of a patient, frontline healthcare workers, and billing. “Why does my Tylenol cost $10 per tablet, but the 1,000-count  bottle I have at home was purchased for $3?” This question is often difficult to answer and may lead to unintended operational consequences.    Tue, 28 Feb 2023 22:23:10 +0000 https://traffic.libsyn.com/secure/87d4129a-590b-43bb-a0af-5ff85eec4eed/20230222_Self_Administered_Drug_-_Refresh.mp3?dest-id=3288863 https://traffic.libsyn.com/secure/87d4129a-590b-43bb-a0af-5ff85eec4eed/20230222_Self_Administered_Drug_-_Refresh.mp3?dest-id=3288863 Self-administered drugs (SAD) have been a long-standing controversy when administered in a hospital outpatient setting from the perspectives of a patient, frontline healthcare workers, and billing. “Why does my Tylenol cost $10 per tablet, but the 1,000-count  bottle I have at home was purchased for $3?” This question is often difficult to answer and may lead to unintended operational consequences.    Tue, 28 Feb 2023 22:23:10 +0000 https://traffic.libsyn.com/secure/87d4129a-590b-43bb-a0af-5ff85eec4eed/20230222_Self_Administered_Drug_-_Refresh.mp3?dest-id=3288863 https://traffic.libsyn.com/secure/87d4129a-590b-43bb-a0af-5ff85eec4eed/20230207_Botox_PA.mp3?dest-id=3288863 The new year brings a new focus on resolutions including prior authorization processes. In July 2020, Medicare implemented a prior authorization process for select services including botulinum toxin. Its time to revisit workflow processes and, if not exempt, confirm with respective teams that a prior authorization is obtained prior to providing the service. Tue, 07 Feb 2023 20:22:07 +0000 https://traffic.libsyn.com/secure/87d4129a-590b-43bb-a0af-5ff85eec4eed/20230207_Botox_PA.mp3?dest-id=3288863 https://traffic.libsyn.com/secure/87d4129a-590b-43bb-a0af-5ff85eec4eed/20230207_Botox_PA.mp3?dest-id=3288863 The new year brings a new focus on resolutions including prior authorization processes. In July 2020, Medicare implemented a prior authorization process for select services including botulinum toxin. Its time to revisit workflow processes and, if not exempt, confirm with respective teams that a prior authorization is obtained prior to providing the service. Tue, 07 Feb 2023 20:22:07 +0000 https://traffic.libsyn.com/secure/87d4129a-590b-43bb-a0af-5ff85eec4eed/20230207_Botox_PA.mp3?dest-id=3288863